Research location
Ocala
Florida, United States
Advertisement
Research activity in Ocala
Florida, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 559 trials and 601 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Ocala
559 linked trials · page 3 of 12Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2NCT05438498 · 2022-06-03 · 1 site observation
TERMINATED
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseNCT05310071 · 2022-06-02 · 1 site observation
TERMINATED
The REMIND Study- SPARK Neuro Software StudyNCT05406778 · 2022-05-18 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)NCT05256134 · 2022-04-19 · 1 site observation
TERMINATED
CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in LungNCT05306288 · 2022-04-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsNCT05169437 · 2022-03-15 · 1 site observation
TERMINATED
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)NCT05103358 · 2022-03-10 · 2 site observations
COMPLETED
STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle GlaucomaNCT05280366 · 2022-02-09 · 1 site observation
UNKNOWN
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)NCT05013229 · 2021-11-30 · 1 site observation
COMPLETED
A Study of NDI 1150-101 in Patients With Solid TumorsNCT05128487 · 2021-11-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)NCT04968184 · 2021-11-05 · 1 site observation
TERMINATED
Simufilam 100 mg for Mild-to-Moderate Alzheimer's DiseaseNCT04994483 · 2021-11-03 · 1 site observation
COMPLETED
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee OsteoarthritisNCT05064735 · 2021-10-01 · 1 site observation
COMPLETED
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's DiseaseNCT05063539 · 2021-09-16 · 1 site observation
COMPLETED
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)NCT05026866 · 2021-08-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based TherapyNCT04857359 · 2021-08-06 · 1 site observation
TERMINATED
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of HypertensionNCT04518293 · 2021-07-09 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%NCT04986202 · 2021-06-30 · 1 site observation
COMPLETED
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of HypertensionNCT04518306 · 2021-06-14 · 1 site observation
COMPLETED
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung CancerNCT04746924 · 2021-05-24 · 1 site observation
TERMINATED
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's DiseaseNCT04777331 · 2021-05-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood PressureNCT04714320 · 2021-04-28 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT TrialNCT04847557 · 2021-04-20 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight LossNCT04660643 · 2021-03-29 · 1 site observation
COMPLETED
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily InsulinNCT04770532 · 2021-03-05 · 1 site observation
COMPLETED
Open-label Trial in Parkinson's Disease (PD)NCT04760769 · 2021-02-24 · 1 site observation
COMPLETED
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseNCT04750226 · 2021-02-18 · 1 site observation
COMPLETED
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)NCT04751487 · 2021-02-12 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney DiseaseNCT04595370 · 2021-01-26 · 1 site observation
COMPLETED
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)NCT04374253 · 2021-01-26 · 1 site observation
TERMINATED
A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseNCT04619420 · 2021-01-06 · 1 site observation
TERMINATED
Global Prevalence of ATTR-CM in Participants With HFpEFNCT04424914 · 2020-12-30 · 1 site observation
TERMINATED
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)NCT04622319 · 2020-12-04 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast CancerNCT04539938 · 2020-12-01 · 1 site observation
COMPLETED
Study of Exchange of Travoprost Intraocular ImplantNCT04615403 · 2020-11-19 · 1 site observation
COMPLETED
A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)NCT04592341 · 2020-11-18 · 1 site observation
TERMINATED
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's DiseaseNCT04380142 · 2020-10-19 · 1 site observation
COMPLETED
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesNCT04560998 · 2020-10-01 · 1 site observation
COMPLETED
Breast Cancer Liquid Biopsy TrialNCT04962529 · 2020-09-28 · 1 site observation
UNKNOWN
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)NCT04542499 · 2020-09-23 · 1 site observation
COMPLETED
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCNCT04140526 · 2020-09-16 · 1 site observation
ACTIVE_NOT_RECRUITING
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLCNCT04265534 · 2020-07-24 · 1 site observation
TERMINATED
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced MalignanciesNCT04561362 · 2020-07-17 · 1 site observation
ACTIVE_NOT_RECRUITING
TTX-080 HLA-G Antagonist in Subjects With Advanced CancersNCT04485013 · 2020-07-14 · 1 site observation
ACTIVE_NOT_RECRUITING
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate AmyloidNCT04468659 · 2020-07-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)NCT04437511 · 2020-06-19 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesNCT04255433 · 2020-05-29 · 1 site observation
COMPLETED
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.NCT04153929 · 2020-04-30 · 1 site observation
COMPLETED
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersNCT04306900 · 2020-03-30 · 1 site observation
COMPLETED
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205NCT04241068 · 2020-03-02 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.